相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Matthew T. Chang et al.
NATURE BIOTECHNOLOGY (2016)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer
Tatsuya Yoshida et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype
Feimeng Zheng et al.
NATURE COMMUNICATIONS (2016)
Non-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cells
Lee M. Butcher et al.
NATURE COMMUNICATIONS (2016)
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures
Karsten Boehnke et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC
Y. Takahashi et al.
ANNALS OF ONCOLOGY (2015)
Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
T. T. Seppala et al.
BRITISH JOURNAL OF CANCER (2015)
Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data
M. Nunes et al.
CANCER RESEARCH (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Ascl2 Acts as an R-spondin/Wnt-Responsive Switch to Control Stemness in Intestinal Crypts
Jurian Schuijers et al.
CELL STEM CELL (2015)
Regulation of Endothelial Cell Proliferation and Vascular Assembly through Distinct mTORC2 Signaling Pathways
Shan Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
The genomic landscape of response to EGFR blockade in colorectal cancer
Andrea Bertotti et al.
NATURE (2015)
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Alexandre Calon et al.
NATURE GENETICS (2015)
Stromal contribution to the colorectal cancer transcriptome
Claudio Isella et al.
NATURE GENETICS (2015)
A Big Bang model of human colorectal tumor growth
Andrea Sottoriva et al.
NATURE GENETICS (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
Eugenia R. Zanella et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
Enzo Medico et al.
NATURE COMMUNICATIONS (2015)
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
Mihaela Angelova et al.
GENOME BIOLOGY (2015)
Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche
Hayley Davis et al.
NATURE MEDICINE (2015)
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
Martin J. Aryee et al.
BIOINFORMATICS (2014)
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
D. J. Jonker et al.
BRITISH JOURNAL OF CANCER (2014)
SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
Christopher A. Miller et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition
Katherine E. Hutchinson et al.
CLINICAL CANCER RESEARCH (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey et al.
LANCET (2013)
Metrics other than potency reveal systematic variation in responses to cancer drugs
Mohammad Fallahi-Sichani et al.
NATURE CHEMICAL BIOLOGY (2013)
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
David T. W. Jones et al.
NATURE GENETICS (2013)
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
Felipe De Sousa E Melo et al.
NATURE MEDICINE (2013)
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Anguraj Sadanandam et al.
NATURE MEDICINE (2013)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The ConsensusPathDB interaction database: 2013 update
Atanas Kamburov et al.
NUCLEIC ACIDS RESEARCH (2013)
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Laetitia Marisa et al.
PLOS MEDICINE (2013)
Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines
Andreas Schlicker et al.
BMC MEDICAL GENOMICS (2012)
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
Sylvia Julien et al.
CLINICAL CANCER RESEARCH (2012)
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
Carsten Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2012)
Recurrent R-spondin fusions in colon cancer
Somasekar Seshagiri et al.
NATURE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids
Paul Mason et al.
PLOS ONE (2012)
The Mammalian DM Domain Transcription Factor Dmrta2 Is Required for Early Embryonic Development of the Cerebral Cortex
Daijiro Konno et al.
PLOS ONE (2012)
Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel
Shazad Q. Ashraf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
Dindel: Accurate indel calls from short-read data
Cornelis A. Albers et al.
GENOME RESEARCH (2011)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion
Ruibin Xi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
Kimio Yonesaka et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
A flexible R package for nonnegative matrix factorization
Renaud Gaujoux et al.
BMC BIOINFORMATICS (2010)
5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
Koh Miura et al.
Cancers (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non-Small Cell Lung Cancers
Eva Lin et al.
MOLECULAR CANCER RESEARCH (2009)
Transcriptome analysis by strand-specific sequencing of complementary DNA
Dmitri Parkhomchuk et al.
NUCLEIC ACIDS RESEARCH (2009)
An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer
Andrew E. Teschendorff et al.
PLOS ONE (2009)
The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation
Zheng Wang et al.
CANCER RESEARCH (2008)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab
Shirin Khambata-Ford et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Pvclust: an R package for assessing the uncertainty in hierarchical clustering
R Suzuki et al.
BIOINFORMATICS (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas
KS Bishnupuri et al.
GASTROENTEROLOGY (2006)
Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice
CL Morton et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Multiple SVM-RFE for gene selection in cancer classification with expression data
KB Duan et al.
IEEE TRANSACTIONS ON NANOBIOSCIENCE (2005)
Anticancer drug response and expression of molecular marker in early-passage xenotransplanted colon carcinomas
I Fichtner et al.
EUROPEAN JOURNAL OF CANCER (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Model-based clustering, discriminant analysis, and density estimation
C Fraley et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)
分享论文
